A midpoint assessment of the American Cancer Society challenge goal to halve the U.S. cancer mortality rates between the years 1990 and 2015

T ByersAmerican Cancer Society Incidence and Mortality Ends Committee


The American Cancer Society has challenged the U.S. to reduce cancer mortality rates 50% over the 25 years from 1990 to 2015. The current report is an analysis and commentary on progress toward that goal through 2002, the midpoint of the challenge period. Cancer mortality rates were examined from 1990 through 2002, and projections to the Year 2015 were made. Cancer deaths that were prevented or deferred by the declining death rates were expressed as the difference between the observed and projected numbers of deaths and the numbers that would have been observed over that period had the 1990 death rates persisted. Since 1990, cancer mortality rates have been declining in the U.S. by approximately 1% per year. Trends especially have been favorable for cancers of the breast, prostate, and colorectum and for lung cancer among men. Should this rate of decline continue over the coming decade, death rates from cancer will be approximately 23% lower in the Year 2015 than they were in 1990, and approximately 1.8 million deaths from cancer will have been prevented or deferred. At this midpoint of the 25-year challenge period, it appears that fully reaching the goal will require substantial breakthroughs in cancer early detection and/or i...Continue Reading


Dec 30, 1993·The New England Journal of Medicine·S J WinawerJ F Panish
Feb 24, 2001·Controlled Clinical Trials·John K GohaganProstate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Sep 18, 2001·JAMA : the Journal of the American Medical Association·A H MokdadJ P Koplan
Jan 5, 2002·International Journal of Cancer. Journal International Du Cancer·Harry J de KoningInternational Prostate Cancer Screening Trials Evaluation Group
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwWriting Group for the Women's Health Initiative Investigators
Nov 1, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D L Wickerham
Jun 26, 2003·The New England Journal of Medicine·Ian M ThompsonCharles A Coltman
Jul 24, 2003·JAMA : the Journal of the American Medical Association·Jarmo VirtamoATBC Study Group
Jan 8, 2004·JAMA : the Journal of the American Medical Association·Adam L HershRandall S Stafford
Feb 6, 2004·Annals of Internal Medicine·Jennifer S HaasKarla Kerlikowske
Apr 6, 2004·CA: a Cancer Journal for Clinicians·Elizabeth WardMichael J Thun
Nov 2, 2004·Obstetrics and Gynecology·Diana S M BuistLarry Kessler
Jan 20, 2005·Journal of the National Cancer Institute·Scott M LippmanCharles A Coltman
Jan 22, 2005·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Feb 4, 2005·The New England Journal of Medicine·Jeffrey A Meyerhardt, Robert J Mayer
Mar 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark D PegramGwen Fyfe
Sep 17, 2005·CA: a Cancer Journal for Clinicians·Kenneth J Pienta, David C Smith
Oct 6, 2005·Journal of the National Cancer Institute·Brenda K EdwardsLinda W Pickle
Oct 21, 2005·The New England Journal of Medicine·Martine J Piccart-GebhartHerceptin Adjuvant (HERA) Trial Study Team
Oct 28, 2005·The New England Journal of Medicine·Donald A BerryCancer Intervention and Surveillance Modeling Network (CISNET) Collaborators


Nov 4, 2011·Nature Reviews. Clinical Oncology·Vincent T DeVita
Jun 1, 2012·The New England Journal of Medicine·Vincent T DeVita, Steven A Rosenberg
Jul 1, 2010·Journal of the National Cancer Institute·David LimsuiPaul J Limburg
Jan 15, 2010·Annual Review of Public Health·T Byers
May 11, 2011·International Journal of General Medicine·Zeina NahlehMeenakshi Mal
Nov 18, 2008·European Journal of Gastroenterology & Hepatology·Josepa RibesJosep Maria Borràs
Aug 19, 2008·Surgery·Anees B ChagparKelly M McMasters
Mar 14, 2007·Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society·Kunio Doi
Apr 10, 2007·The Journal of Surgical Research·Anees B Chagpar, Kelly M McMasters
Feb 28, 2007·Journal of Surgical Oncology·Stephen F Sener
Feb 4, 2010·Journal of the American Geriatrics Society·T Byers
Oct 24, 2013·Cancer·Kelly E IrwinWilliam F Pirl
Jan 26, 2010·CA: a Cancer Journal for Clinicians·Alan G Thorson
Dec 20, 2008·American Journal of Surgery·Beatrix A SlomianyAnees B Chagpar
Jun 14, 2006·Cancer·J S MarksKaren K Gerlach
Nov 16, 2006·Proceedings·Gavin Melmed

Related Concepts

American Cancer Society
Objective (Goal)
Malignant Neoplasms
Cigar smoker

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.